Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Mymetics Corp. (OTC: MYMX).

Full DD Report for MYMX

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.05050.0550.0550.049869,500
2018-12-130.0550.0540.0550.053151,683
2018-12-120.05920.05050.05920.0505136,587
2018-12-110.05990.05940.060.05929,775
2018-12-100.05920.05920.060.059229,800

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1420,00069,50028.7770Cover
2018-12-13101,417151,68366.8612Short
2018-12-1290,000136,58765.8921Short
2018-12-114,0009,77540.9207Short
2018-12-0611,64386,38913.4774Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MYMX.


About Mymetics Corp. (OTC: MYMX)

Logo for Mymetics Corp. (OTC: MYMX)

Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation vaccines for infectious and life threatening diseases. Mymetics core technology and expertise are in the use of virosomes, lipid based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins. Mymetics currently has the following vaccines in its pipeline: HIV/AIDS. intranasal Influenza, RSV, Malaria and Chikungunya.

 

Contact Information

 

 

Current Management

  • Ronald Kempers / President, CEO
  • Sylvain Fleury / CSO
  • Toon Stegmann / Chief Scientific Officer
  • Carmelina Mahrer / Director, Fin.
  • Ulrich Burkhard /
  • Thomas Staehelin /
  • Ernest M. Stern /

Current Share Structure

  • Market Cap: $7,897,698 - 03/12/2018
  • Authorized: 1,000,000,000 - 03/29/2016
  • Issue and Outstanding: 303,757,622 - 11/13/2017
  • Float: 91,064,968 - 03/29/2016

 


Recent Filings from (OTC: MYMX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 23 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 29 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 13 2017

 

 


Daily Technical Chart for (OTC: MYMX)

Daily Technical Chart for (OTC: MYMX)


Stay tuned for daily updates and more on (OTC: MYMX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MYMX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MYMX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MYMX and does not buy, sell, or trade any shares of MYMX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/